Dr. Charles A. Staley is a specialist in the surgical treatment of stomach, esophageal, appendiceal, colorectal, pancreas, liver cancer, and peritoneal surface malignancies. He is the Program Director for the Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Program for patients with peritoneal cancers from gastric, colorectal, mesothelioma, and pseudomyxoma peritonei cancers.

He has a strong interest in translational research and novel clinical trials in gastrointestinal cancers and has investigated gene therapy for metastatic colon cancer and radiofrequency ablation with intra-arterial chemotherapy for patients with colorectal liver metastases.

Dr. Staley received his MD with honors from Dartmouth Medical School in 1987 and completed his general surgery residency at the University Health Center of Pittsburgh and his surgical oncology fellowship at M.D. Anderson Cancer Center. He is recognized for his clinical and research interests in the treatment of gastrointestinal and liver cancer and has won awards such as the M.D. Anderson Clinical Fellows Research Award and a Clinical Fellowship Award from the American Cancer Society.

Upon completing his fellowship in 1995, he was appointed Holland M. Ware Professor in Surgical Oncology and Chief of the Division of Surgical Oncology of the Department of Surgery, Emory University School of Medicine. He coordinates national efforts for clinical cancer research through his role in the Eastern Cooperative Oncology Group and as Chair of the Vizient UHC Cancer Center Network Steering Committee. He can be reached at the Atlanta VA Medical Center and Emory University Hospital. Phone: (404) 778-0210.